Warnakulasuriya K A A S, Robinson D, Evans H
Department of Oral Medicine & Pathology, Guy's, King's and St Thomas' Dental Institute & WHO Collaborating Centre for Oral Cancer and Precancer, Demark Hill Campus, Caldecot Road, London SE5 9RW, UK.
J Oral Pathol Med. 2003 Sep;32(8):443-9. doi: 10.1034/j.1600-0714.2003.00179.x.
Successful initial treatment of oral and oro-phayngeal cancer has led to the emergence of second primary tumours (SPTs). Population data are meagre.
Occurrence of multiple primary cancers following a malignancy in a head and neck site was computed using data from a population-based cancer registry covering a population of 14 million.
Among 59,958 subjects reported to the registry, 5.5% males and 3.6% females developed a second primary cancer. At the sites studied, a total of 2771 second primary cancers were found, compared with an expected number of 2341. The standardised incidence ratio (SIR) for contracting a new primary cancer was 1.14 (95% CI=1.09-1.19) for men and 1.34 (95% CI=1.24-1.44) for women. There was a significantly increased risk for a second cancer in most of the upper aerodigestive tract sites that are generally regarded as tobacco associated, with an SIR for subsequent oral cancer of 5.56 in men and 15.31 in women. Subjects first detected with a pharyngeal cancer experienced the highest SIR for a subsequent tumour. Excluding tobacco-associated sites, the risk of a subsequent cancer was not significantly raised in either sex (SIR 0.87 (95% CI 0.81-0.93) for men; SIR 0.99 (95% CI 0.90-1.09) for women).
The relative risk for multiple primary cancer was higher in younger subjects, those detected with a head and neck cancer during the 1990s as compared with earlier decades of the study, and among patients who received radiotherapy for their first tumour. By 20 years from the time of the first head and neck cancer, we estimate that approximately 30% of male patients and 20% of female patients will have developed an SPT.
口腔和口咽癌的成功初始治疗导致了第二原发肿瘤(SPTs)的出现。人群数据匮乏。
利用一个覆盖1400万人口的基于人群的癌症登记处的数据,计算头颈部部位恶性肿瘤后多原发癌的发生率。
在向登记处报告的59958名受试者中,5.5%的男性和3.6%的女性发生了第二原发癌。在所研究的部位,共发现2771例第二原发癌,而预期数量为2341例。男性患新原发癌的标准化发病比(SIR)为1.14(95%可信区间=1.09 - 1.19),女性为1.34(95%可信区间=1.24 - 1.44)。在大多数通常被认为与烟草相关的上呼吸消化道部位,患第二癌的风险显著增加,男性后续口腔癌的SIR为5.56,女性为15.31。首次被检测出患有咽癌的受试者后续肿瘤的SIR最高。排除与烟草相关的部位,男女患后续癌症的风险均未显著升高(男性SIR为0.87(95%可信区间0.81 - 0.93);女性SIR为0.99(95%可信区间0.90 - 1.09))。
年轻受试者、与研究早期几十年相比在20世纪90年代被检测出头颈部癌的患者以及首次肿瘤接受放疗的患者中,多原发癌的相对风险更高。从首次头颈部癌发病起20年后,我们估计约30%的男性患者和20%的女性患者将发生第二原发肿瘤。